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Abstract
Background: The scarcity of certain nucleic acid species and the small size of target sequences such as miRNA,
impose a significant barrier to subcellular visualization and present a major challenge to cell biologists. Here, we
offer a generic and highly sensitive visualization approach (oligo fluorescent in situ hybridization, O-FISH) that can
be used to detect such nucleic acids using a single-oligonucleotide probe of 19–26 nucleotides in length.
Results: We used O-FISH to visualize miR146a in human and avian cells. Furthermore, we reveal the sensitivity of
O-FISH detection by using a HIV-1 model system to show that as little as 1–2 copies of nucleic acids can be
detected in a single cell. We were able to discern newly synthesized viral cDNA and, moreover, observed that
certain HIV RNA sequences are only transiently available for O-FISH detection.
Conclusions: Taken together, these results suggest that the O-FISH method can potentially be used for in situ
probing of, as few as, 1–2 copies of nucleic acid and, additionally, to visualize small RNA such as miRNA. We further
propose that the O-FISH method could be extended to understand viral function by probing newly transcribed viral
intermediates; and discern the localisation of nucleic acids of interest. Additionally, interrogating the conformation
and structure of a particular nucleic acid in situ might also be possible, based on the accessibility of a target
sequence.
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Background
Visualising nucleic acids in situ may provide highly signifi-
cant biological information at a cellular level. Detecting
nucleic acid in a single cell routinely employs fluorescence
in situ hybridization (FISH). Traditionally, FISH requires
the use of single probes labelled with multiple fluo-
rophores [1-6] or multiple probes labelled with a single
fluorophore [7-9] to allow visualization (for review see
[10]). Recent advances in the use of rolling circle amplifi-
cation from padlock probes [11] and branched DNA
probes [12] have significantly improved signal to noise ra-
tios as well as sensitivity during FISH detection. However,
the requirement for relatively large target sequences
makes these approaches unsuitable for visualizing small
size RNAs, such as miRNAs. Alternative approaches in-
clude molecular beacons [13], MS2-GFP [14], quantum
dots [15] or sub-diffraction microscopy, however, have in-
herent technical and instrumentation constraints, making
them impractical for mainstream use to answer biological
questions.
To improve the limitations of nucleic acid detection, we
modified a commercially available proximity ligation assay
(PLA) to detect individual copies of nucleic acids. PLA
was originally designed for detecting co-localization of
proteins within a 40 nm distance [16]. The intended de-
tection of co-localized proteins via PLA relies on the use
of primary antibodies to the proteins of interest and two
species-specific secondary antibodies conjugated to short
DNA sequences, which can interact with two short DNA
oligonucleotides to form a circularized sequence. This se-
quence is then ligated, amplified via rolling circle DNA
polymerization, and the amplified sequences are hybrid-
ized with fluorescent oligonucleotide probes, resulting in
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an approximate two hundred-fold amplification of the ori-
ginal signal.
Here we have modified the PLA technology to visualise
nucleic acids in fixed cells. The method incorporates
probing target nucleic acid sequences with a modified
FISH protocol combined with detection of probe binding
with a commercially available PLA based kit (we have
termed this method O-FISH). Initially, target-specific oli-
gonucleotides coupled with biotin are hybridised to the
gene of interest. Subsequently an anti-biotin primary anti-
body is used to bind to the biotin labelled probe, and
finally the PLA method detects the conjugated target
complex to generate an O-FISH signal (Figure 1). In this
study we have used O-FISH to visualize miR146a in both
mammalian and avian cells, demonstrating its capacity to
detect miRNAs. In addition, we used a HIV-1 model
system to illustrate the sensitivity of O-FISH detection,
which may reach as little as 1–2 copies of nucleic acids in
a single cell. In this model we were able to detect both
HIV-1 genomic RNA and newly synthesized viral cDNA
allowing visualisation of nucleic acids at various stages of
the viral reverse transcription process. Unexpectedly, we
also observed that certain HIV RNA sequences are only
transiently available for O-FISH detection, implying O-
FISH can potentially be used for in situ probing of tem-
poral nucleic acid structures.
Results and discussion
To test the O-FISH technology we used a HIV-1 virus
system since the viral genome has a well-defined copy
number within each HIV-1 virion. For retroviruses, such
as HIV-1, two near identical copies of the RNA genome
are packaged into the virion [17], which makes HIV-1
-infected cells excellent reference samples to assess
the sensitivity and specificity of this novel nucleic acid
detection system. A biotinylated 26-nucleotide probe
targeting the HIV-1 pol region (Pol, see Figure 2 for rela-
tive genome position) was used to detect the presence of
HIV-1 RNA genomes in HIV-1 infected lymphoid cells.
O-FISH signals were detected in the HIV-1 infected cells
(Figure 3b), at levels clearly discernible from minimal
background signals observed in the mock-infected con-
trol (Figure 3a). The data demonstrates that O-FISH Pol
RNA detection is highly specific and is able to distin-
guish HIV-1 nucleic acids from host cellular RNA. In
addition we have shown that fluorescently labelled HIV-1
virions do not co-localise during infection, (Figure 3c-e),
therefore the observed O-FISH signals are derived from
independent viral RNA genomes (Figure 3b). These data
indicate that the O-FISH procedure may detect as few as
2 copies of nucleic acid.
In order to probe for cDNA viral replicative products in
HIV-1 infected cells we used two additional biotinylated
Figure 1 Overview of the O-FISH mechanism. Target nucleic acids are initially hybridised with a biotintylated complimentary oligonucleotide
probe (step 1). The biotin conjugate is then targeted with an anti-biotin monoclonal antibody (mAb; step 2). The proximal ligation assay (PLA)
consisting of a + and – mAb, is then employed to target the specific IgG domain of the biotin-bound mAb (step 3). Oligos conjugated to each of
the PLA mAbs are then hybridised to form circularised DNA (step 4) and then rolling circle amplification is used to effectively multiply the target
sequence (step 5). Fluorescently labelled oligonucleotide probes are then hybridized with the rolling circle amplified DNA allowing the
observation of target with fluorescence microscopy.
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26-nucleotide probes. Early viral cDNA products were
detected using a negative sense probe targeting strong stop
cDNA and intermediate viral cDNA products using a
probe targeting gag cDNA (see Figure 2 for relative
genome position). The time course experiments show the
detection of increasing viral cDNA products over time by
quantitative PCR (qPCR) (Figure 4). When O-FISH was
targeted to strong stop cDNA and gag cDNA in MT2 cells
there was an increase in O-FISH signals at 4–6 hours
post-infection relative to the mock-infected control
(Figure 5a, b). The O-FISH signals detected using the
strong stop and gag probes throughout the infection time
course are consistent with the observations of strong stop
cDNA and gag cDNA identified by qPCR (Figure 4),
suggesting that the strong stop cDNA and gag cDNA de-
tection by the O-FISH method reflects the biology of the
Figure 2 Probe sequence detection during reverse transcription. Coloured bars spatially represent the nucleic acid sequence detected by
each O-FISH probe. The pol probe (light green) detects positive sense viral genomic RNA until its degradation during minus strand DNA
elongation and it also detects very late stage plus strand DNA synthesis (plus strand DNA elongation). The U5/PBS probe (light blue) detects the
positive sense 5’ LTR section of the viral RNA genome and it also detects the plus strand strong stop (+sss) DNA that occurs immediately before
the second strand transfer. The strong stop probe (purple) detects minus strand strong stop DNA, which is the first segment of DNA produced
during reverse transcription and therefore detects all cDNA from early reverse transcription onwards. The gag probe (dark green) detects all cDNA
from an intermediate point in reverse transcription (after minus strand DNA elongation) onwards. Figure adapted from Telesnitsky & Goff 29.
Jones et al. BMC Cell Biology 2013, 14:21 Page 3 of 10
http://www.biomedcentral.com/1471-2121/14/21
HIV-1 replication-cycle. Furthermore, as it is generally ac-
cepted that only one copy of viral cDNA is derived from
the reverse transcription complex, these data suggest that
our O-FISH probes may detect as little as one copy of
viral nucleic acid, although, this is somewhat complicated
by background levels. To ensure the reproducibility of
these observations, a parallel HIV-1 infection was carried
out with an alternative lymphoid cell line, Jurkat cells,
resulting in similar strong stop cDNA and gag cDNA O-
FISH signals (Figure 5c, d). These data further support the
reliability and reproducibility of our O-FISH method. To
further confirm the reliability of the O-FISH method we
designed experiments to test the specificity of the O-FISH
protocol. Due to the small size of the target nucleic acid
sequences used for detection, the addition of RNase/
DNase enzymatic treatments for background reduction
proved impractical due to the difficulty in achieving the
complete nucleic acid digestion required to abrogate de-
tection. As an alternative, a reverse transcription inhibitor
AZT was used to block synthesis of HIV-1 cDNA and
evaluate the specificity of our strong stop cDNA and gag
cDNA O-FISH signal. Samples were treated with AZT
then analysed at 12 hours post-infection, to allow maximal
HIV-1 replication and thus O-FISH signals. As expected,
there was a dose-dependent reduction of detected HIV-1
Figure 3 O-FISH detection of HIV-1 RNA genome. For HIV-1 nucleic acid detection, MT-2 cells were fixed 6 hrs post mock-infection (a), or
infection with HIV-1 (b), onto glass slides and incubated with O-FISH pol probe targeted towards HIV-1 positive sense genomic RNA. Bound
probe was detected using the O-FISH protocol. O-FISH signals are shown in red and nuclei in blue. Images were derived from a volume
compression of a z-stack of 16 images taken at a 0.4 μm step size. Scale bars, 10 μm (a, b). MT-2 cells were infected with a mixture of equal
amounts of HIVGFP-Vpr and HIVmCh-Vpr (negative co-localization control), fixed after 6 hrs of synchronized infection and imaged (c, d, e). HIVGFP-Vpr
is shown in green (c, e) and HIVmCh-Vpr is shown in red (d, e) and a merged HIVGFP-Vpr and HIVmCh-Vpr image is shown (e). The provided image
was derived from a volume compression of a z-stack of 25 images taken at a 0.5 μm step size. Scale bars, 5 μm (c, d and e). Nuclei were labelled
with Hoechst 33258 (blue). All micrographs are representative of at least 5 images per condition.
Figure 4 Quantitative PCR (qPCR) analyses of viral replicative
cDNA during early HIV-1 infection. MT2 cells were either mock-
infected or infected with HIV-1 and then lysed for qPCR analyses at
0, 2, 4 or 6 hrs post-infection. HIV-1 cDNA synthesis was quantified
by qPCR using primers to detect early (strong stop) or intermediate
(gag) reverse-transcription products. HIV-1 cDNA copies were
normalized to cell numbers using CCR5 DNA.
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viral cDNA in the presence of AZT (Figure 6), which
additionally demonstrates the specificity of the strong stop
cDNA and gag cDNA O-FISH method.
The O-FISH method was also used to examine struc-
tural rearrangements of nucleic acid targets. We again
used HIV-1 as a model since HIV-1 RNA may undergo
structural rearrangements in the early steps of the repli-
cation cycle [18-20] and thus may limit the O-FISH
probe binding to its target due to the initial occupancy
of the primer binding site by tRNA and the absence of
newly transcribed viral cDNA. Moreover, there is a lack
of direct evidence examining the structural rearrange-
ment hypothesis from HIV-1 infected cells [21] thus
prompting the use of OFISH to examine structural con-
formational changes. To examine the HIV-1 structural
conformations, a biotinylated 24 nucleotide probe was
targeted towards the 5’UTR region of the HIV-1 RNA
genome to assess the accessibility of HIV-1 5’ U5/primer
binding site (PBS) sequence during the early phase of
infection (U5/PBS, Figure 2 for the relative genome pos-
ition). We have found that the 5’ R-PBS sequence was
transiently available for our 5’ U5/PBS O-FISH detection
at 2 hours post-infection with reduced levels of detection
at 0 and 4 hours post-infection as seen in both MT2
(Figure 7a) and Jurkat (Figure 7b) HIV-1 infected cells.
Whilst the reduction of 5’ U5/PBS sequences between 2
and 4 hours post-infection is as expected and can be
explained by RNaseH mediated degradation of HIV-1
Figure 5 O-FISH analyses of viral replicative cDNA during early HIV-1 infection. MT-2 (a, b) and Jurkat (c, d) cells were either mock-
infected or infected with HIV-1 and then fixed onto glass slides at 0, 2, 4 or 6 hrs post-infection. Cells were incubated with O-FISH probes to
detect either early (strong stop) (a, c) or intermediate (gag) (b, d) HIV-1 cDNA reverse-transcription products (see Figure 2 for relative genome
position). Bound probes were detected using the O-FISH method. Quantification of signal events was performed using the spots function in
Bitplane Imaris Software. Data shown are mean (+/− SEM) signals per cell, derived from a minimum of 5 images per condition. O-FISH were
counted in approx 120–150 cells over 24–36 fields for each of the 4 panels. Paired two-tailed t-tests were performed to determine the
significance level of the data sets.
Figure 6 O-FISH analyses of viral replicative cDNA after
blocking with AZT reverse transcriptase inhibitor. MT2 cells were
infected with HIV-1 in the absence or presence of AZT at 0.1 μg/ml
or 10 μg/ml concentration. Cells were fixed onto glass slides at
either 20 min or 12 h post-infection and subjected to the O-FISH
protocol using probes to detect both strong stop cDNA and gag
cDNA. The O-FISH signals were compared to the respective AZT-
untreated controls at 12 hrs post-infection. Images were analysed
using Imaris software. Data shown are mean (+/− SEM) signals per
cell, derived from a minimum of 5 images per condition. O-FISH
signals were counted in a total of 158 cells (91 cells over 29 fields
for the gag probe and 67 cells over 29 fields for the strong
stop probe).
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RNA genome, the increase in detected 5’ U5/PBS se-
quences between 0 and 2 hours post-infection was an
unexpected observation.
As the HIV-1 RNA genome is not replicated in infected
cells until later time-points this increase is not due to an
increase in the number of RNA genomes in the cell. In-
stead, we suggest that the increase in detected signals
results from either the differential occupancy of primer
tRNA on the PBS and/or structural rearrangements of
viral RNA genomes during the early steps of HIV infec-
tion. RNA rearrangement is likely to be a critical regulator
of HIV-1 biology [22] and is therefore an area of much
research. The O-FISH method has the potential to
provide a means to interrogate the conformational re-
arrangement of HIV RNA during replication or RNA
structural rearrangements in general and thus may pro-
vide supporting data for speculated RNA structures.
To validate whether O-FISH can detect small size RNAs
that are as small as miRNA, we used a 19-nucleotide O-
FISH probe to detect miR146a expression levels in both
chicken DF1 and human HeLa cells. MiR146a levels are
linked to the control of type 1 interferon [23], and are al-
tered upon stimulation during virus infection [24] or virus
mimics such as dsRNA polyinosinic: polycytidylic (pIC)
[23]. Upon pIC treatment, significant differential patterns
of miR146a distribution were seen in both DF1 (Figure 8c,
d) and HeLa (Figure 8g, h) cells. The contrasting changes
in miR146a levels induced by pIC treatment in the cell
types tested (down-regulated in DF1 [Figure 8d] and up-
regulated in HeLa [Figure 8h]) were in agreement with
qRT-PCR analysis (Figure 8a, e). Minimal background
signal was detected when the biotinylated miR146a probe
was not used in the O-FISH reaction (Figure 8b, f), illus-
trating O-FISH can be used to detect small RNA sequences
that are ~20 nucleotides in length, such as miR146a.
The data shown here not only provide a proof of con-
cept for the O-FISH protocol but also demonstrates
specific detection of both the HIV-1 positive sense RNA
genome of infecting virions and viral cDNA generated
from reverse transcription in the natural target cells of
HIV-1. The use of very short oligo probes combined
with a novel signal amplification method provide the
flexibility for this method to be used to detect very short
nucleic acid target sequences in cells. Here we have
established that this allows both the detection of specific
cDNA products, which are often both short and scarce
in nature, during the HIV-1 reverse transcription process
and native cellular miRNAs. In addition, we have ob-
served data that suggests this method can also be ap-
plied to probing RNA structure and binding events. This
method has the potential to be expanded to detection of
viral nucleic acids in additional virus models providing
an important tool for biologists to unravel complex viral
transcriptional processes. Furthermore, the ability of this
method to detect short cellular nucleic acid sequences,
such as miRNAs, shows that O-FISH can be easily
adapted for use outside the field of virology, and may
prove to be a useful tool for examining more general
processes in cell biology.
Conclusions
In summary, our data show that O-FISH can detect low
copy numbers of nucleic acids that are as little as 20-
nucleotides in length. Additionally, O-FISH provides a
new method to identify the subcellular distribution of
nucleic acids and miRNAs during biological processes.
Furthermore, by taking advantage of certain newly syn-
thesized viral nucleic acids that are unique to infectious
viral particles, O-FISH could also be used to discern and
Figure 7 O-FISH analyses of RNA conformational
rearrangements during early HIV-1 infection. MT2 cells (a) and
Jurkat cells (b) were either mock-infected or infected with HIV-1 and
then fixed onto glass slides at 0, 2 or 4 hrs post-infection and
incubated with a HIV-1 O-FISH probe to detect plus strand U5/PBS
RNA(see Figure 2 for relative genome position). Images were
analysed using Imaris software. Data shown are mean (+/− SEM)
signals per cell, derived from a minimum of 5 images per condition.
O-FISH signals were counted in a total of 160 cells (61 cells over 29
fields for the MT2 cells and 91 cells over 20 fields for the
Jurkat cells).
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track the low percentage of functional viruses during
infection. Moreover, O-FISH may provide data to support
hypothesised RNA structural rearrangements as we have
observed in the context of HIV-1.
Methods
Cell culture
293T cells were maintained in Dulbecco's modified Eagle
medium/high modified (with 4500 mg/l dextrose and
Figure 8 O-FISH detection of miR146a. DF1 chicken fibroblasts and HeLa cells were either mock-transfected (b, c, f, g) or transfected with pIC
(DF1: 10 μg/ml [d], HeLa: 5 μg/ml [h]) for 3 hrs and then analysed by qRT-PCR. qRT-PCR data are shown for DF1 cells (a) and HeLa cells (e). O-
FISH detection procedure (lacking O-FISH miR146 probe) was carried out as a negative control (DF1 [b], HeLa [f]). The O-FISH signals following
mock-transfection in DF1 cells (c) and HeLa cells (g) are shown, and pIC-treatment of DF1 cells (10 μg/ml) (d) and HeLa cells (5 μg/ml) (h) are
shown. Bound probe was detected using the O-FISH method. Micrographs are representative of at least 5 images per condition. Nuclei were
labelled with Hoechst 33258. O-FISH signals are shown in red and nuclei in blue. The provided images were derived from a volume compression
of a z-stack of 16 images taken at a 0.4 μm step size. Scale bar of 25 μm applies to DF1 and HeLa cells (b-d, f-h).
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4 mM L-glutamine) medium (DMEM; Invitrogen,
Carlsbad, CA, USA) supplemented with 10% (vol/vol)
heat-inactivated cosmic calf serum (CCS; Hyclone,
Tauranga, New Zealand) and 100 U/ml of penicillin/
streptomycin (P/S) (Invitrogen). MT-2 and Jurkat cells
(obtained through the AIDS Research and Reference
Reagent Program, Division of AIDS, NIAID, NIH) were
cultured in Rosewell Park Memorial Institute (RPMI)
1640 medium (Invitrogen) supplemented with 10% vol/vol
heat-inactivated fetal calf serum (FCS; Invitrogen) and P/S.
HeLa cells (American Type Culture Collection [ATCC],
CCL-2) and chicken fibroblast cell line DF1 (ATCC,
CRL-12203) were maintained in DMEM supplemented
with 10% FCS, 2 mM glutamine, 1.5% sodium bicarbonate
and P/S.
Virus production and purification
HIV virus stocks were produced by poly(ethylenimine)
(PEI; Polysciences Inc., Warrington, PA, USA) co-trans-
fection of 293T cells with the full length HIV-1 plasmid
DNA pNL4.3 (obtained through the National Institutes of
Health AIDS Reagents Program from Dr. Malcolm Martin
[25]) and either the EGFP-Vpr fusion protein expressing
plasmid pEGFP-Vpr or the mCherry-Vpr fusion protein
expressing plasmid mCherry-Vpr (a kind gift from Prof.
Tom Hope, Northwestern University, Chicago) to produce
HIVGFP-Vpr and HIVmCh-Vpr.. Cells were counted and
plated at 1 × 106 cells per plate onto 10 cm tissue-culture
plates in 6 ml of media. Twenty-four hours later cells were
transfected with 2.5 μg of plasmid DNA (1.875 μg of
pNL4.3 and 0.625 μg of pEGFP-Vpr) at a 9:1 PEI:DNA
ratio. Twelve hours post-transfection cells were washed
twice with phosphate buffered saline (calcium and magne-
sium free; PBS-) and fresh media added. Supernatants
were collected 36 hours post-transfection and cellular
debris removed by sequential filtration through 0.8 μm
and 0.45 μm sterile syringe filters (Sartorius, Goettingen,
Germany) . Virus particles were then concentrated by
ultracentrifugation through a 20% sucrose cushion using
an L-90 ultracentrifuge (SW-41 rotor, Beckman Coulter,
Fullerton, CA, USA) at 100,000 × g for 1 h at 4°C. Pellets
were then resuspended in Benzonase buffer [20 mM
Tris–HCl pH 8.0, 2 mM MgCl2, 20 mM NaCl] and
treated with 90 units/ml Benzonase (Sigma-Aldrich, St.
Louis, MO, USA) for 30 min at 37°C to remove any con-
taminating plasmid DNA. The concentrated viral stocks
were quantified using the Vironostika HIV-1 antigen (p24
CA) MicroELISA assay (bioMèrieux, Marcy l'Etoile, France)
according to the manufacturer’s instructions and frozen in
single-use aliquots at −80°C.
Infection of lymphoid cells
Synchronized infections were performed as described
previously [26]. MT-2 or Jurkat cells were spinoculated
with 300 ng p24 CA, as determined by Vironostika HIV-1
antigen (p24 CA) MicroELISA assay (bioMèrieux, Marcy
l'Etoile, France) virus per 1 × 106 cells for 2 h at 1,200 × g
in either 12 or 24 well plates at a non fusion-permissive
temperature (15°C). After spinoculation, cells were washed
twice with PBS- to remove unbound virus and incubated
with warm media at 37°C, 5% CO2 to initiate infection.
Removal of extracellular plasma membrane proteins and
un-entered virus using pronase
As part of the experiment using the RT inhibitor AZT
pronase treatment was used 20 minutes post-infection to
remove all proteins from the outside of the cells, thus re-
moving any bound but un-entered virions from the cell
surface. Twenty minutes post-spinoculation cells were
washed and resuspended in ice-cold Hank's Balanced Salt
Solution (HBSS, Invitrogen) containing 2 mg/ml of prote-
ase from Streptomyces griseus (pronase E; Sigma-Aldrich)
for 10 min on ice. Cells were then washed extensively with
HBSS containing 10% FCS then fresh media added and
the cells incubated at 37°C.
Reverse-transcription inhibition using Zidovudine (AZT)
The RT inhibitor Zidovudine (AZT) was obtained
through the AIDS Research and Reference Reagent Pro-
gram, Division of AIDS, NIAID, NIH. AZT was added
to cell culture supernatants at the point of infection at
either 0.1 or 10 μg/ml as separate conditions. AZT was
maintained in the cell culture supernatant throughout
the infection.
Modulation of miRNA levels via synthetic nucleic acids
Introduction of synthetic nucleic acids to DF1 or HeLa
cells were carried out using the transfection reagent
Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions. Briefly, polyinosinic-polycytidylic
acid (pIC) was diluted to 10 times the intended final
concentration in media, and Lipofectamine was diluted
into media at 1 μL / cm2 of well area. After 5 min the
Lipofectamine and pIC were combined 1:1, incubated
for 15 min and then added to cell culture as per manu-
facturer’s instructions (Invitrogen).
Quantitative PCR for HIV-1 reverse transcription products
Quantification of HIV-1 reverse transcription products
and standardization of cell numbers was performed
using quantitative PCR (qPCR). Cells were harvested at
various time points post-infection and lysed in PCR lysis
buffer containing 10 mM Tris [pH 8.0], 50 mM KCl with
0.5% vol/vol Triton-X100, 0.5% vol/vol NP-40 and
75 mg/ml proteinase K (Roche, Basel, Switzerland). Sam-
ples were incubated at 56°C for 2 h before the proteinase
K was inactivated by heating to 95°C for 10 min. Sam-
ples were then stored at −20°C. Quantitative PCR was
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performed on an MX3000P QPCR machine (Agilent,
Santa Clara, CA, USA). Each PCR reaction contained 1×
Brilliant II SYBR Green Master mix (Agilent), 400 nM
each primer and 5 μl of cell lysates (1:10 dilution) in a
15 μl reaction volume. The HIV-1 specific primers
M667 (sense; 50-GGCTAACTAGGGAACCCACTG-30)
and AA55 (antisense; 50-CTGCTAGAGATTTTCCACA
CTGAC-30) were used to detect early HIV-1 cDNA ([−]
strong-stop DNA). The HIV-1 specific primers M667
(sense; 50-GGCTAACTAGGGAACCCACTG-30) and
M661 (antisense; 50-CCTGCGTCGAGAGATCTCCTCT
GG-30) were used to detect intermediate HIV-1 reverse
transcription products (LTR/gag, post 2nd strand trans-
fer). HIV-1 PCR conditions were an initial denaturation
at 95°C for 15 min followed by 40 rounds of cycling at
95°C for 10 s, then 60°C for 30 s. Cell numbers were
standardized for the human CCR5 gene using the
primers LK46 (sense; 50-GCTGTGTTTGCGTCTCTCC
CAGGA-30) and LK47 (antisense; 50-CTCACAGCCC
TGTGCCTCTTCTTC-30). CCR5 PCR conditions were
an initial denaturation at 95°C for 15 min followed by 40
rounds of cycling at 95°C for 20 s, 58°C for 40 s and
72°C for 40 s.
Quantitative reverse transcription-PCR (qRT-PCR) analyses
of miRNA
RNA was harvested using Tri-reagent (Sigma-Aldrich)
according to the manufacturer’s instructions. One μg of
extracted RNA was subjected to DNase treatment using
a DNase 1 kit (Sigma-Aldrich) according to the manu-
facturer’s instructions. The DNase treated RNA was then
polyadenylated with 300 units of polyadenylase polymer-
ase to a final volume of 20 μl and incubated at 37°C for
30 min, then 95°C for 5 min similar to the method by
Shi et al. [27]. The miRNA was reverse-transcribed to
complimentary DNA (cDNA) using a Superscript III first
strand synthesis kit (Invitrogen) according to the manu-
facturer’s instructions then diluted to 1:20. qRT-PCR
was carried out using Sybr Green (applied biosystems)
and the comparative threshold cycle method, to derive
fold change, previously described by Bannister et al.,
(2011). The forward primer sequence miR146 (5’GCG
TGA GAA CTG AAT TCC ATG GG) and the endogen-
ous control miR5.8S (5’ TGG GAA TAC CGG GTG
CTG T) were individually amplified with a universal re-
verse primer (5’ GAG GCG AGC ACA GAA TTA ATA
CGA C) to generate Ct values for analyses similar to
Bannister et al. [28].
O-FISH detection of HIV-1 nucleic acids and miR146
Cells were fixed with either 4% formaldehyde in PBS- at
4°C overnight (HIV analyses) or in 300 μl methanol for
20 min at 20°C (miR146 analyses) and then washed twice
in PBS-. Fixed cells were mounted onto slides using a
Cytospin II machine (Shandon, Astmoore, UK) at 67 × g
for 5 minutes. The slides were removed and air-dried
overnight in the dark. Slides were either processed imme-
diately or stored in sealed bags at −20°C until needed. All
reactions were performed as open-droplet reactions with a
droplet volume of 15 μl. Cells were rehydrated in PBS- for
5 minutes and permeabilised with 0.2% Triton for 6 -
minutes, then washed twice with PBS- before being
treated with 0.005% pepsin (Sigma-Aldrich) in 0.01N HCl
for 1 min(pepsin treatment was omitted in the miR146
analyses) and then again washed twice with PBS-. O-FISH
probe stocks were then diluted to a final concentration of
500 nM in hybridisation buffer (10 mM TRIS [pH7.4],
600 mM NaCl, 1 mM EDTA, 10 nM DTT, 0.1% SDS, 50%
formamide) and added to the cells, which were incubated
in a humidity chamber at 37°C for 1 hour. Cells were
washed twice with PBS- and blocked in blocking buffer
(Olink Bioscience, Uppsala, Sweden) at 37°C for 30 -
minutes. Probe binding was detected via incubation with
an anti-biotin primary antibody (Sigma-Aldrich), diluted
1:500 for HIV-1 nucleic acids or 1:1500 for miR146 in
antibody diluent (Olink Bioscience) in a humidity cham-
ber at room temperature for 30 minutes. Detection of
primary antibody binding was carried out using Duolink II
anti-mouse PLA probes and detection kit (Olink bio-
science) as per the manufacturer’s instructions. After O-
FISH detection, the cells were counterstained with Hoechst
33258 (Invitrogen) and then mounted in Fluoromount-G
(Electron Microscopy Sciences, Hatfield, PA, USA) or
mounted directly using fluromount with DAPI (Olink Bio-
science) for miRNA microscopy.
O-FISH Probes used for RNA and cDNA detection
Probes were designed complementary to different parts
of the HIV-1 RNA genome, to HIV-1 cDNA synthesised
at various stages of the reverse-transcription process, or
to miR146. Negative sense probes pol (5’ CTG TCA
GTT ACA TAT CCT GCT TTT CC 3’) and U5/PBS (5’
CGG GCG CCA CTG CTA GAG ATT TTC 3’) were
used to detect positive sense HIV-1 RNA. Positive sense
probes gag (5’ ATG GGT GCG AGA GCG TCG GTA
TTA AG 3’) and strong stop (5’ TGT GAC TCT GGT
AAC TAG AGA TCC CT 3’) were used to detect nega-
tive sense HIV-1 cDNA. The miRNA probe (5’ CCC ATG
GAA TTC AGT TCT C) was used to detect miR146a. All
probes had a biotin molecule conjugated to their 5’ end.
Image acquisition and analysis
For HIV O-FISH analysis, images were acquired using
either a DeltaVision-RT (Applied Precision, Issaquah, WA,
USA) or Zeiss Axio Observer Z1 (Zeiss) microscope. Images
taken on the DeltaVision-RT were acquired in a z-series on
a charge-coupled device (CCD) camera (CoolSnap HQ;
Photometrics, Tucson, AZ, USA) through either a 60X 1.42
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numerical aperture (NA) or a 100X 1.4 NA oil immersion
lens. Reference brightfield images were also acquired. Im-
ages were deconvolved using softWoRx deconvolution soft-
ware (Applied Precision) before analysis. All images taken
on the Zeiss Axio Observer Z1 were taken in a z-series on a
charge-coupled device (CCD) camera (AxioCam MRm
Rev. 3, Carl Zeiss, Germany) through a 100X 1.30 NA oil
immersion lens. Reference differential interference contrast
images (DIC) were also acquired. Images of a minimum of
5 fields were taken per slide for analysis for all experiments.
Cell images were analysed by quantification of fluorescent
signal using Bitplane Imaris software (Bitplane AG,
Zurich, Switzerland). For miRNA analyses, similar proce-
dures were used but the samples were imaged using a
Leica (Leica Microsystems, Sydney) SP5 confocal micro-
scope. Fluorescence and DIC images were collected and
all images were taken with the same microscope parame-
ters. Quantification of O-FISH signal events was
performed using the spots function in Imaris (Bitplane
AG, Switzerland). O-FISH signals were designated to be at
least 0.5 μm in diameter and intensity was determined on
an experimental basis for each set of slides. The total
number of O-FISH signals was divided by the number of
nuclei for each image. The mean for each sample was then
calculated from an average of between 13.4 and 30 cells
per time point and condition from at least five randomly
acquired images (resulting in data being derived from a
total of between 120 and 160 cells per panel in each
figure) and is reported as ‘signals per cell’.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
software (GraphPad Software Inc., San Diego, CA, USA).
Paired two-tailed t-tests were used to compare variance
between two sets of observations as indicated.
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